Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Der Unfallchirurg
|
February 1, 1994
[Baker's cysts. A follow-up study after surgical therapy]
F G Scherf, L Hillejan, H W Krawzak, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 27, 1999
Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome
P C Cassina, M Hauser, L Hillejan, et al.
Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
February 5, 2002
[Neoadjuvant chemotherapy and chemoradiotherapy in surgically treated non-small-cell stage III bronchial carcinoma]
L Hillejan, M R Müller, W Eberhardt, et al.
The Annals of Thoracic Surgery
|
October 30, 1999
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results
G Stamatis, W Eberhardt, G Stüben, et al.
Pneumologie (Stuttgart, Germany)
|
December 18, 2002
[Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer]
A Marra, L Hillejan, C Pöttgen, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 10, 2001
Completion pneumonectomy: current indications, complications, and results
T Fujimoto, G Zaboura, S Fechner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial
C Pöttgen, W Eberhardt, S Bildat, et al.
Molecular Diagnosis & Therapy
|
October 7, 2006
Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction
D Kemming, U Vogt, N Tidow, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 19, 2016
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC
L H Schmidt, A Kuemmel, C Schliemann, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Der Unfallchirurg
|
February 1, 1994
[Baker's cysts. A follow-up study after surgical therapy]
F G Scherf, L Hillejan, H W Krawzak, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 27, 1999
Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome
P C Cassina, M Hauser, L Hillejan, et al.
Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
February 5, 2002
[Neoadjuvant chemotherapy and chemoradiotherapy in surgically treated non-small-cell stage III bronchial carcinoma]
L Hillejan, M R Müller, W Eberhardt, et al.
The Annals of Thoracic Surgery
|
October 30, 1999
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results
G Stamatis, W Eberhardt, G Stüben, et al.
Pneumologie (Stuttgart, Germany)
|
December 18, 2002
[Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer]
A Marra, L Hillejan, C Pöttgen, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 10, 2001
Completion pneumonectomy: current indications, complications, and results
T Fujimoto, G Zaboura, S Fechner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial
C Pöttgen, W Eberhardt, S Bildat, et al.
Molecular Diagnosis & Therapy
|
October 7, 2006
Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction
D Kemming, U Vogt, N Tidow, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 19, 2016
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC
L H Schmidt, A Kuemmel, C Schliemann, et al.
Page
of 2